ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,864.67
      0.40%
      US Tech 100
      19,783.20
      0.68%
      Dow Jones
      43,275.91
      0.09%
      Brent Oil
      72.935
      0.00%
      Bitcoin
      68,357.38
      0.00%
      Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. UK
      5. LSE

      6. Roche Holding Ag (0QQ6) Quote

      Roche Holding Ag

      Roche Holding Ag (0QQ6)

      LSE
      229.20
      0.00
      (0.00%)
      Closed October 20 11:30AM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      229.20
      Bid
      0.00
      Ask
      0.00
      Volume
      1,349
      0.00 Day's Range 0.00
      229.20 52 Week Range 229.20
      Market Cap
      -
      Previous Close
      229.20
      Open
      -
      Last Trade
      344
      @
      297.96628
      (O)
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      5,185
      Shares Outstanding
      0.00
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -
      Revenue
      58.72B
      Net Profit
      11.5B

      About Roche Holding Ag

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.roche.com
      Headquarters
      Basel, Che
      Founded
      -
      Roche Holding Ag is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker 0QQ6. The last closing price for Roche was CHF229.20. Over the last year, Roche shares have traded in a share price range of CHF 229.20 to CHF 229.20.

      Roche currently has 0 shares outstanding.

      Ask ADVFN Intelligence (AI)

      0QQ6 Latest News

      More News

      Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study

      Roche’s Vabysmo improved vision in underrepresented populations with diabetic macular edema (DME) in a first-of-its-kind study The ELEVATUM study showed clinically meaningful improvement in vision...

      October 18 2024
      UK Regulatory

      Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate

      Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate Positive data confirm Evrysdi efficacy...

      October 14 2024
      UK Regulatory

      FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

      FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation Approval is based on Phase III INAVO120 results...

      October 11 2024
      UK Regulatory

      Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY

      Roche obtains CE certification for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY The new VENTANA...

      October 10 2024
      UK Regulatory

      Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis

      Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis Positive phase III results for Roche’s Gazyva/Gazyvaro show...

      September 26 2024
      UK Regulatory

      Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses

      Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses New TAGS (Temperature-Activated Generation of Signal...

      September 24 2024
      UK Regulatory

      WHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions

      WHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions...

      September 23 2024
      UK Regulatory

      Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses

      Positive phase III results show Xofluza significantly reduces the transmission of influenza viruses Data from the CENTERSTONE study shows single-dose Xofluza reduces transmission of influenza from...

      September 19 2024
      UK Regulatory

      FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis

      FDA approves OCREVUS ZUNOVO™ as the first and only twice-a-year 10-minute subcutaneous injection for people with relapsing and progressive multiple sclerosis OCREVUS ZUNOVO™ has the potential to...

      September 16 2024
      UK Regulatory

      FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy

      FDA approves Roche’s Tecentriq Hybreza, the first and only subcutaneous anti-PD-(L)1 cancer immunotherapy Tecentriq Hybreza provides patients and physicians with greater flexibility of treatment...

      September 13 2024
      UK Regulatory
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      100229.2229.2229.27645229.2DE
      400229.2229.2229.27935229.2DE
      1200229.2229.2229.25185229.2DE
      2600229.2229.2229.24058229.2DE
      5200229.2229.2229.25185229.2DE
      15600229.2229.2229.26049229.2DE
      26000229.2229.2229.24780229.2DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      MTCMothercare Plc
      5.20p
      (46.07%)
      		4.48M
      HEMOHemogenyx Pharmaceuticals Plc
      1.47p
      (31.96%)
      		46.49M
      WSBNWishbone Gold Plc
      0.375p
      (25.00%)
      		36.38M
      PRIMPrimorus Investments Plc
      4.15p
      (18.57%)
      		1.53M
      DKEDukemount Capital Plc
      0.0395p
      (17.91%)
      		336.77M
      FUTRFuture Plc
      805.00p
      (-18.19%)
      		3.07M
      KOOKooth Plc
      234.00p
      (-17.61%)
      		565.33k
      GFINGfinity Plc
      0.0175p
      (-16.67%)
      		32.42M
      MILAMila Resources Plc
      0.55p
      (-15.38%)
      		3.57M
      CHSSWorld Chess Plc
      3.25p
      (-13.33%)
      		405.35k
      MSMNMosman Oil And Gas Limited
      0.0495p
      (0.20%)
      		949.08M
      NTVONativo Resources Plc
      0.0026p
      (0.00%)
      		913.6M
      TRPTower Resources Plc
      0.0295p
      (-3.28%)
      		573.77M
      DKEDukemount Capital Plc
      0.0395p
      (17.91%)
      		336.77M
      PREMPremier African Minerals Limited
      0.0425p
      (-7.61%)
      		250.76M

      Discussion

      View Full Feed
      Cake Eater Cake Eater 9 minutes ago
      NH seems to be very confident…..that speaks volumes.
      ELTP
      Krombacher Krombacher 12 minutes ago
      SSC, let’s cut through the noise and focus on facts. You continue to cling to the narrative that everything wrong with ERHC is due to management failures, dry wells, and toxic debt. Sure, those things have played a part, but the truth is that short sellers have been manipulating this stock for years
      ERHE
      Zardiw Zardiw 14 minutes ago
      And WAY different than 2021.......or 2017

      Z
      BIEL
      BigCat BigCat 14 minutes ago
      Would be nice to see some insiders buy some shares here... but this crew in charge hasn't ever purchased any. The last time any insiders ever bought shares was way back when Chuck Ponicki was in charge. That was pre-RS, when this was trading below $1. Those were the days...
      CIBH
      Zardiw Zardiw 16 minutes ago
      $DDAmanda Chart on $REGRF:

      https://DDAmanda.com/Charts/DDAmandaREGRF.jpg

      https://DDAmanda.com

      Z
      DDAMANDA REGRF
      BigCat BigCat 18 minutes ago
      They definitely need to grow their pile of capital a bit before they think about dividends... but I would imagine that should be a goal here. Unless the goal is to actually get absorbed by some larger entity or a merger with another small community bank... then the dividend doesn't really make much
      CIBH
      TrendTrade2016 TrendTrade2016 19 minutes ago
      AAGFF/AAG.V THIS PURE SILVER PLAY IS ABOUT TO FLY...ERIC SPROTT INCREASES HIS STAKE
      AAGFF
      Zardiw Zardiw 19 minutes ago
      $DDAmanda Chart on $RITE:

      https://DDAmanda.com/Charts/DDAmandaRITE.jpg

      https://DDAmanda.com

      Z
      DDAMANDA RITE
      Omar8 Omar8 19 minutes ago
      Oilin07,



      "Had a nice cash out. Looking for re entey"


      Good job ! Have you looked at Pvgdf ? if so what do you think ?
      SNWGF
      TrendTrade2016 TrendTrade2016 22 minutes ago
      the biggest gold boom since 1978 and hiru sinks to all time lows...a scam is a scam and the clowns will go down with the ship
      HIRU
      Zardiw Zardiw 22 minutes ago
      Something to Consider:

      https://DDAmanda.com/Charts/Thanks.jpg

      https://DDAmanda.com

      Z
      Rh2022 Rh2022 24 minutes ago
      Her husband will be doing the clinical trial with DCVax, Keytruda and Poly ICLC.
      NWBO
      TrendTrade2016 TrendTrade2016 24 minutes ago
      gold to 3000////silver to 50 bucks...just like in 1978 when i was 15 years old....history is about to repeat itself as the gold cup and handle weekly breakout takes place...
      RDAR
      Zardiw Zardiw 26 minutes ago
      Something to Consider:

      https://DDAmanda.com/Charts/Thanks.jpg

      https://DDAmanda.com

      Z
      Zardiw Zardiw 27 minutes ago
      Something to Consider:

      https://DDAmanda.com/Charts/Thanks.jpg

      https://DDAmanda.com

      Z
      TrendTrade2016 TrendTrade2016 29 minutes ago
      yes..like your mind...i schooled you many times in 2024...ilst asii...now i'm going to school u here and the first lesson is you will never see a breakout...watch and learn...i'm here to stay and this is now my little project to school the clowns
      ZHUD
      Zardiw Zardiw 30 minutes ago
      Something to Consider:

      https://DDAmanda.com/Charts/Thanks.jpg

      Z
      yp_1 yp_1 31 minutes ago
      Also, SVE, specifically for you: https://www.google.com/search?q=rhetorical+question+meaning&rlz=1CDGOYI_enCA753US753&oq=&gs_lcrp=EgZjaHJvbWUqCQgBECMYJxjqAjIHCAAQRRiwATIJCAEQIxgnGOoCMgkIAhAjGCcY6gIyCQgDECMYJxjqAjIJCAQQIxgnGOoCMgkIBRAjGCcY6gIyCQgGEC4YJxjqAjIJCAcQIxgnGOoCMgkICBAjGCcY6gIyCQgJECMYJxjqAj
      SEV
      arachnodude arachnodude 33 minutes ago
      LMAO>>>"Allegations..."

      Try only one to produce this in reality:

      https://investorshub.advfn.com/uimage/uploads/2023/12/16/hvnjkKBLB_SILK.jpeg

      Keep grinding away...

      https://investorshub.advfn.com/uimage/uploads/2024/8/17/iiqnvgrindax.gif
      KBLB
      arachnodude arachnodude 37 minutes ago
      Specific amounts were provided in those studies? Beyond that, what quantities are you expecting from KBLB?
      KBLB
      BoyWidaDreamOr2 BoyWidaDreamOr2 39 minutes ago
      If it was guaranteed it would be priced in. Buy as many or as little based on your risk appetite.
      ELTP
      Sltan Sltan 40 minutes ago
      From the expert market
      To the main stock exchange
      From 0.0001 to 00
      RNVA
      SunnyConqueror67 SunnyConqueror67 42 minutes ago
      If Vyvanse was guaranteed to be approved, I wouldn't see much risk in investing in ELTP. I believe this is the biggest 'what if?' we have right now. If I'm wrong, feel free to correct me :)
      ELTP

      Your Recent History

      LSE
      0QQ6
      Roche
      Delayed Upgrade Clock